<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="073455-2018"
            EDITION="2018034">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-075716-001</RECEPTION_ID>
      <DELETION_DATE>20190215</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>34</NO_OJ>
         <DATE_PUB>20180217</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 034-073455</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:073455-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>http://www.nhsbt.nhs.uk</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33141625">Diagnostic kits</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33140000">Medical consumables</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UK">UNITED KINGDOM</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UK">UNITED KINGDOM</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180215</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="0">Prior information notice without call for competition</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="9">Not applicable</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="9">Not applicable</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B01</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Комплекти за диагностициране</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostické sady</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostiske sæt</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnoseausrüstung</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Εξοπλισμοί διάγνωσης</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostic kits</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Kits para diagnóstico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostikakomplektid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostiikkasarjat</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Kits de diagnostic</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostic kits</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Dijagnostička oprema</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnosztikai készletek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Materiale diagnostico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostikos rinkiniai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostikas komplekti</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Settijiet tad-dianjożi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnosesets</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Zestawy diagnostyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Kits de diagnóstico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Truse de diagnosticare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnostické súpravy</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Kompleti za diagnosticiranje</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Filton</TI_TOWN>
            <TI_TEXT>
               <P>Diagnoskits</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">NHS Blood &amp; Transplant</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F01_2014 CATEGORY="ORIGINAL" FORM="F01" LG="EN">
         <NOTICE TYPE="PRI_ONLY"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>NHS Blood &amp; Transplant</OFFICIALNAME>
               <ADDRESS>North Bristol Park</ADDRESS>
               <TOWN>Filton, Bristol</TOWN>
               <POSTAL_CODE>BS34 7QH</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <E_MAIL>marta.drozdzowska@nhsbt.nhs.uk</E_MAIL>
               <n2016:NUTS CODE="UK"/>
               <URL_GENERAL>http://www.nhsbt.nhs.uk</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT ITEM="1">
            <TITLE>
               <P>Automated NGS DNA library preparation kits</P>
            </TITLE>
            <CPV_MAIN>
               <CPV_CODE CODE="33141625"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>NHSBT is seeking to engage with suppliers who can supply commercial kits to prepare DNA libraries which are suitable for Human Leucocyte Antigen (HLA) Class I and Class II typing by next generation sequencing (NGS) on the Illumina MiSeq NGS platform. There will also be an additional requirement of an approved automated protocol for use with Beckman Coulter Biomek liquid handling robots. Other UK Blood Services and the Irish Blood Transfusion Service will be included as beneficiaries. There will be a supplier engagement day on 21.3.2018 and please contact Marta Drozdzowska (marta.drozdzowska@nhsbt.nhs.uk) to confirm your participation. See II.2.4 for more details.</P>
            </SHORT_DESCR>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33140000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <SHORT_DESCR>
                  <P>NHS Blood &amp; Transplant (NHSBT) intends to undertake an OJEU tender exercise for the supply of a commercial kit to prepare DNA libraries. The DNA libraries must be suitable for Human Leucocyte Antigen (HLA) Class I and Class II typing by next generation sequencing (NGS) on the Illumina MiSeq NGS platform. The kit must prepare a DNA library from pre-prepared PCR amplicons, ranging in size from 5 kb to 11 kb, comprising of the full length of a HLA gene, and be capable of multiplexing a minimum of 192 samples. In addition, the commercial kit must have an approved automated protocol for use with Beckman Coulter Biomek liquid handling robots, with the option to perform the process manually for contingency planning requirements. Finally, the solution must allow the HLA Class I and Class II typing of at least 10 000 blood and haematopoietic stem cell donor registry donor samples per annum.</P>
                  <P>Prior to commencing the formal procurement process, and to help inform our strategy, NHSBT would like to consult the market to improve our knowledge of all current and future systems available over the next four years to assess their potential application. This will aid identification of opportunities and gauge market interest in this field.</P>
                  <P>Histocompatibility &amp; Immunogenetics (H&amp;I) is a strategic business function of NHS Blood and Transplant that provides a portfolio of testing, advice and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology.</P>
                  <P>These services are supplied through a national network of six laboratories located at NHSBT Colindale, Birmingham, Filton (Bristol), Newcastle, Sheffield, and Tooting. These services support the diagnosis and/or treatment of a variety of medical conditions and are relevant in the following clinical areas:</P>
                  <P>— solid organ transplantation and clinical advice for donor selection,</P>
                  <P>— haematopoietic stem cell transplantation and clinical advice for donor selection,</P>
                  <P>— blood transfusion and transfusion reactions (SHOT),</P>
                  <P>— platelet refractoriness and provision of HLA/HPA selected components,</P>
                  <P>— platelet immunology,</P>
                  <P>— granulocyte immunology,</P>
                  <P>— immunogenetics including diagnostic testing and pharmacogenetics,</P>
                  <P>— haematopoietic stem cell donor registry typing.</P>
                  <P>Information gained from this exercise will be used to inform production of a detailed specification and subsequent advertisement through the OJEU route.</P>
                  <P>Building on our strengths as a national provider, our strategic aim is for NHSBT H&amp;I services to become the preferred provider and supplier of choice for H&amp;I related services in the NHS.</P>
                  <P>We would like to work with future suppliers to realise this ambition and to perform HLA typing by next generation sequencing technologies in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers, donors and the patients we serve.</P>
                  <P>It is NHSBT's intention to hold a pre-procurement engagement day on 21.3.2018 in London. To enable NHSBT to finalise arrangements (e.g. send meeting location details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to Marta.Drozdzowska@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 9.3.2018. This should include a list of your potential attendees and a brief of overview (or a website link) of the Goods/Services which might be offered. Please include options, if available, to offer a managed service contract.</P>
               </SHORT_DESCR>
            </OBJECT_DESCR>
            <DATE_PUBLICATION_NOTICE>2018-04-09</DATE_PUBLICATION_NOTICE>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <CONTRACT_COVERED_GPA/>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <DATE_DISPATCH_NOTICE>2018-02-15</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F01_2014>
   </FORM_SECTION>
</TED_EXPORT>
